CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma

Yongjun Cha, Yu Jung Kim, Se-Hoon Lee, Tae-Min Kim, Seung Hong Choi, Dong-Wan Kim, Chul-Kee Park, Il Han Kim, Jee Hyun Kim, Eunhee Kim, Byungse Choi, Chae-Yong Kim, In Ah Kim, Dae Seog Heo

Cancer Research and Treatment. 2017;49(1):129-140. Published online 2016 May 18 DOI: https://doi.org/10.4143/crt.2015.466

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma

Yongjun Cha, Yu Jung Kim, Se-Hoon Lee, Tae-Min Kim, Seung Hong Choi, Dong-Wan Kim, Chul-Kee Park, Il Han Kim, Jee Hyun Kim, Eunhee Kim, Byungse Choi, Chae-Yong Kim, In Ah Kim, Dae Seog Heo

Cancer Research and Treatment. 2017;49(1):129-140

Link1

Link2 Link3

Bevacizumab in recurrent malignant glioma

Lauren E. Abrey

Current Neurology and Neuroscience Reports. 2008;8(3):233-234

Link1

Link2 Link3

Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma

Carlos Kamiya-Matsuoka, Mohamed A. Hamza, John F. de Groot

Journal of Clinical Neuroscience. 2020;74:36-40

Link1 Link2

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients

Maximilian Niyazi, Nathalie Lisa Jansen, Maya Rottler, Ute Ganswindt, Claus Belka

Radiation Oncology. 2014;9(1):

Link1

Link2 Link3 Link4

Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial

Shingo Takano, Eiichi Ishikawa, Kei Nakai, Tomohiko Masumoto, Tetsuya Yamamoto, Akira Matsumura, Masahide Matsuda

OncoTargets and Therapy. 2014;1551

Link1

8747 POSTER Single Agent Bevacizumab for Recurrent Malignant Glioma

K. Cadoo, M. O'Brien, L. Grogan, O. Breathnach

European Journal of Cancer. 2011;47:S588

Link1 Link2

EP-1333: Re-recurrence pattern after re-irradiation with bevacizumab in recurrent malignant glioma

M. Niyazi, N.J. Jansen, M. Rottler, U. Ganswindt, C. Belka

Radiotherapy and Oncology. 2015;115:S720

Link1 Link2

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience

Tanja Mesti, Maja Ebert Moltara, Marko Boc, Martina Rebersek, Janja Ocvirk

Radiology and Oncology. 2015;49(1):80-85

Link1 Link2

A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma

Tina Mayer, Jill Lacy, Joachim Baehring

Clinical medicine. Oncology. 2008;2:CMO.S827

Link1 Link2 Link3

8702 ORAL A Phase II, Multicenter, Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab Alone in Japanese Patients With Recurrent Malignant Glioma

M. Matsutani, R. Nishikawa, H. Kobayashi, S. Takano, N. Shinoura, M. Nagane, Y. Narita, T. Aoki, K. Sugiyama, J. Kuratsu

European Journal of Cancer. 2011;47:S575

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.